SORRY, THE PAGE YOU ARE LOOKING FOR CANNOT BE FOUND
Please check the URL or return to the homepage.
Non-Hodgkin’s Lymphoma (NHL)
RIABNI™ (rituximab-arrx) is indicated for the treatment of adult patients with:
Chronic Lymphocytic Leukemia (CLL)
RIABNI™, in combination with fludarabine and cyclophosphamide (FC), is indicated for the treatment of adult patients with previously untreated and previously treated CD20-positive CLL.
Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA)
RIABNI™, in combination with glucocorticoids, is indicated for the treatment of adult patients with Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA).
Please check the URL or return to the homepage.